Ganga Pharmaceuticals Ltd
Incorporated in 1989, Ganga Pharmaceuticals Ltd is in the business of manufacturing & trading in Ayurvedic pharmaceuticals & allied products[1]
- Market Cap ₹ 6.53 Cr.
- Current Price ₹ 13.5
- High / Low ₹ 27.1 / 9.25
- Stock P/E 326
- Book Value ₹ 13.2
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.02 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Promoter holding has decreased over last 3 years: -10.7%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | |
|---|---|---|
| 3.08 | 2.37 | |
| 2.70 | 2.34 | |
| Operating Profit | 0.38 | 0.03 |
| OPM % | 12.34% | 1.27% |
| 0.17 | 0.25 | |
| Interest | 0.24 | 0.19 |
| Depreciation | 0.05 | 0.05 |
| Profit before tax | 0.26 | 0.04 |
| Tax % | 23.08% | 50.00% |
| 0.19 | 0.02 | |
| EPS in Rs | 0.47 | 0.05 |
| Dividend Payout % | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -89% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 10% |
| 1 Year: | -43% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | |
|---|---|---|
| Equity Capital | ||
| Reserves | ||
| Total Liabilities | ||
| CWIP | ||
| Investments | ||
| Total Assets |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | |
|---|---|---|
| -0.31 | -0.18 | |
| 0.37 | 0.28 | |
| -0.29 | -0.10 | |
| Net Cash Flow | -0.22 | 0.00 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | |
|---|---|---|
| Debtor Days | ||
| Inventory Days | ||
| Days Payable | ||
| Cash Conversion Cycle | ||
| Working Capital Days | ||
| ROCE % |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
22 Apr - Resignation of Company Secretary Ms. Priti Kothari Bhaiya effective April 22, 2025 due to personal reasons.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
22 Apr - Confirms non-applicability of Large Corporate criteria as per SEBI circular for FY ending March 2025.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Apr - Certificate for dematerialization of shares received.
-
Announcement under Regulation 30 (LODR)-Change in Management
31 Mar - Cessation of two Independent Directors' terms.
-
Announcement under Regulation 30 (LODR)-Change in Management
31 Mar - Cessation of independent directors after completing their term.
Annual reports
Concalls
-
May 2024TranscriptNotesPPT
Business Overview:[1][2]
Company does production of Ayurvedic Medicines by using techniques strictly as per Ancient text and Ayurved pharma companies. Apart from manufacturing, it is also into marketing and distribution of Bulk Ayurvedic Medicines in Mumbai